PipelineRSS3 days ago
Amprion working to expand access globally to alpha-synuclein protein test
A company called Amprion is partnering with a university in Australia to make their alpha-synuclein test more available around the world. This test detects abnormal proteins in the brain that can help doctors diagnose Parkinson's disease and related conditions earlier and more accurately.
WHY IT MATTERSPatients with suspected Parkinson's disease or similar conditions may gain access to a diagnostic test that can identify their specific condition earlier, potentially allowing for treatment to start sooner.